This one-hour, on-demand, journal article-based activity reviews a large cross-sectional study of kratom consumers to evaluate the potential risk for dependency and addiction with kratom consumption and assess the prevalence of kratom use disorder. Up to this time, research about kratom use bas been limited and the prevalence of Kratom Use Disorder (KUD) and indivudual characteristics associated with KUD has not been well understood. The purpose of this study is to improve to gain a clearer clinical understanding of Kratom Use Disorder and better inform the medical community that interacts with patients who consume kratom about the risks of KUD development.

This one-hour, on-demand, journal article-based activity explores original qualitative research on patient perspectives regarding buprenorphine​ discontinuation in the treatment of opioid use disorder (OUD). Little is currently known about the causes of medication discontinuation from the patient perspective. ​Despite buprenorphine and other medications for OUD being the recommended standard care of treatment for OUD and the benefits of positive health and addiction-related outcomes associated with them​, half of patients discontinue medication use in the first year of treatment. Emerging in interviews with patients with OUD treated with buprenorphine were three main themes related to medication discontinuation: health system barriers, adverse effects (or apparent adverse events) associated with the medication, and patient motivations. The purpose of this activity is to better understand patient perspectives around themes of discontinuation and to explore some clinical strategies to enhance patient retention.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses barriers to withdrawal management and treatment access for people using multiple substances in resource limited communities.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the key clinical takeaways for the treatment of StUD based upon the ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses challenges and barriers to developing a clinical pathway for withdrawal management in a children's hospital.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses how to identify and treat xylazine-associated wounds with patient-centered strategies.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses harm reduction principles and the management of benzodiazepine use disorder.

This 88-hour on-demand conference includes 71 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the complex interactions between substance use, mental health and medical disorders in incarcerated individuals, and the challenges to providing holistic care in this setting.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses how to assess (including laboratory testing and analysis) and manage stimulant toxicity and wash out syndromes related to stimulant abstinence.